SK

Sanjay Kotnala

Active Director Director DIN 08053792
DIN 08053792 First appointment Mar 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2018
Shareholding value •••• Premium profile

About Sanjay Kotnala

Data last updated:

Sanjay Kotnala is a Director at Rayon Medicare Private Limited (since 2018). The company operates in Pharma. Rayon Medicare Private Limited reported revenue of ₹57.5 Lakh (FY 2021).

DIN 08053792
Primary Designation Director
Industry Pharma
First Appointment 08 Mar 2018
Oldest Company Age 8 yrs
Largest company Rayon Medicare Private Limited · ₹57.5 Lakh (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rayon Medicare Private Limited U74999DL2018PTC330489
Director08 Mar 20182018₹57.5 Lakh (FY 2021)Active

Board colleagues of Sanjay Kotnala

NameDINCompanyDesignation
Vijay Singhal08229622Rayon Medicare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Rayon Medicare Private Limited
Premium access

Shareholding and investment profile for Sanjay Kotnala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjay Kotnala

Sanjay Kotnala currently holds 1 directorship: Rayon Medicare Private Limited (Director, since 08 Mar 2018, revenue ₹57.5 Lakh (FY 2021)).

Sanjay Kotnala was first appointed on 08 Mar 2018 as Director at Rayon Medicare Private Limited.

The current boards of Sanjay Kotnala's companies include Vijay Singhal (Rayon Medicare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available